A new study suggests a potential molecular strategy for treating fragile X syndrome, an inherited neurodevelopmental disorder that causes autism spectrum disorder and intellectual disability. This ...
Drugs that act on NMDA (N-methyl-D-aspartate) receptors, which are essential for learning, memory and moment-by-moment consciousness, are key for treating neuropsychiatric disorders. These drugs were ...
Aptinyx is a clinical-stage biotech company with two drug candidates, NYX-458 and NYX-783 aiming to modulate NMDA receptors. A Phase 2 topline data readout of NYX-458 in Parkinson’s disease dementia ...
When it comes to brain proteins, small changes can make a dramatic difference. Researchers studying NMDA (N-methyl-D-aspartate) receptors, which are essential for learning, memory and moment-by-moment ...
Drugs that act on NMDA (N-methyl-D-aspartate) receptors, which are essential for learning, memory and moment-by-moment consciousness, are key for treating neuropsychiatric disorders. These drugs were ...
For the first time, researchers identified the function of the CASKIN2 protein, which plays a key role in precise signal ...
relationship between anti-NMDA receptor encephalitis and vaccination (or tumors). In addition, it is worth mentioning that HPV can cause cancers, and anti-NMDA receptor encephalitis is associated with ...
LA JOLLA, Calif.--(BUSINESS WIRE)--Arialys Therapeutics, a clinical-stage biotechnology company pioneering new precision medicines for autoimmune neuropsychiatric diseases, today announced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback